EUVIMEDEUVIMED entdecken
Crossref

Biofilm Formation Mechanisms in Chronic Infections and its Eradication Strategies: A Review

Hadiza Muhammad

BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE · 01.07.2026 · 10 (2) · 500-513

DOI: 10.64290/bima.v10i2.1630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE, online erschienen am 01.07.2026. Verfasst von Hadiza Muhammad.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biofilm-associated infections account for approximately 80% of clinical infections and represent a major global healthcare problem. These structured microbial communities form on tissues and medical devices, where they enhance antimicrobial resistance and contribute to chronic infections that are difficult to treat. However, a major gap remains in understanding how biofilms behave in vivo and how current diagnostic and antimicrobial susceptibility methods fail to accurately predict treatment outcomes in clinical settings. This review integrates current knowledge on biofilm development, clinical impact, resistance mechanisms, and emerging eradication strategies in chronic and device-related infections. Biofilm formation is a structured developmental process involving several stages like initial attachment, microcolony formation, maturation, and dispersal, regulated by quorum sensing and supported by an extracellular polymeric matrix that provides it with stability and protection. Clinically, biofilms are responsible for chronic infections such as wound infections, cystic fibrosis lung infections, urinary tract infections, and implant-related infections, largely due to high antimicrobial tolerance and immune evasion. Standard susceptibility testing and diagnostic methods fail to capture biofilm physiology, leading to under-diagnosis and treatment failure, while resistance arises from matrix diffusion barriers, metabolic dormancy, and persister cells. Emerging strategies, including enzymatic disruption, quorum sensing inhibition, bacteriophage therapy, and antimicrobial peptides, show improved outcomes particularly when used in combination with antibiotics to target multiple biofilm layers. Overall, understanding biofilm biology and integrating targeted, multi-modal therapies is essential for effectively improving diagnosis, treatment, and prevention of persistent biofilm-related infections in clinical practice.

Zitieren

APA

Muhammad, H. (2026). Biofilm Formation Mechanisms in Chronic Infections and its Eradication Strategies: A Review. BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE, 10(2), 500-513. https://doi.org/10.64290/bima.v10i2.1630

Vancouver

Muhammad H. Biofilm Formation Mechanisms in Chronic Infections and its Eradication Strategies: A Review. BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE. 2026;10(2):500-513. doi:10.64290/bima.v10i2.1630

BibTeX
@article{Muhammad2026,
  author = {Muhammad, Hadiza},
  title = {Biofilm Formation Mechanisms in Chronic Infections and its Eradication Strategies: A Review},
  journal = {BIMA JOURNAL OF SCIENCE AND TECHNOLOGY GOMBE},
  year = {2026},
  volume = {10},
  number = {2},
  pages = {500--513},
  doi = {10.64290/bima.v10i2.1630}
}
Kostenlos starten →